Prosecution Insights
Prosecution Insights
Tech Center 3900 • Art Units: 1618 3991
This examiner grants 68% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17602689 | PROGRAMMABLE POLYMERIC DRUGS | Final Rejection | SONY GROUP CORPORATION |
| 17630286 | CELL PENETRATING PEPTIDE FUNCTIONALIZED PERFLUOROCARBON NANOEMULSION COMPOSITIONS AND METHODS FOR IMAGING CELL POPULATIONS | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18039301 | ROOM-TEMPERATURE PHOSPHORESCENCE NANOPARTICLES AND METHODS OF MAKING THE SAME | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18329245 | CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18549663 | CANCER THERANOSTIC COMPOSITIONS COMPRISING BIGUANIDE COMPLEXES OF GROUP 7 TRANSITION METALS AND USES THEREOF | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17782147 | COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | Non-Final OA | Board of Regents, The University of Texas System |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy